Does FARICIMAB-SVOA Cause Vitreous opacities? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Vitreous opacities have been filed in association with FARICIMAB-SVOA. This represents 0.5% of all adverse event reports for FARICIMAB-SVOA.
10
Reports of Vitreous opacities with FARICIMAB-SVOA
0.5%
of all FARICIMAB-SVOA reports
0
Deaths
2
Hospitalizations
How Dangerous Is Vitreous opacities From FARICIMAB-SVOA?
Of the 10 reports, 2 (20.0%) required hospitalization.
Is Vitreous opacities Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FARICIMAB-SVOA. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does FARICIMAB-SVOA Cause?
Off label use (453)
No adverse event (259)
Death (158)
Visual impairment (146)
Eye inflammation (136)
Blindness (127)
Endophthalmitis (125)
Uveitis (102)
Vitritis (90)
Drug ineffective (82)
What Other Drugs Cause Vitreous opacities?
BROLUCIZUMAB-DBLL (205)
AFLIBERCEPT (148)
RANIBIZUMAB (58)
METHOTREXATE (19)
FARICIMAB\FARICIMAB-SVOA (17)
BEVACIZUMAB (16)
BROLUCIZUMAB (14)
DEXAMETHASONE (14)
TRIAMCINOLONE ACETONIDE (14)
VENLAFAXINE (11)
Which FARICIMAB-SVOA Alternatives Have Lower Vitreous opacities Risk?
FARICIMAB-SVOA vs FARICIMAB\FARICIMAB-SVOA
FARICIMAB-SVOA vs FASLODEX
FARICIMAB-SVOA vs FAVIPIRAVIR
FARICIMAB-SVOA vs FEBUXOSTAT
FARICIMAB-SVOA vs FEDRATINIB